Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2018 | 16 | 1.050 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2018 | 197 | 1.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2023 | 38 | 0.860 |
Why?
|
| Histoplasmosis | 1 | 2023 | 44 | 0.830 |
Why?
|
| Leukapheresis | 2 | 2018 | 17 | 0.720 |
Why?
|
| Epidural Neoplasms | 1 | 2019 | 4 | 0.670 |
Why?
|
| Spinal Cord Compression | 1 | 2019 | 10 | 0.670 |
Why?
|
| Blood Coagulation | 2 | 2017 | 60 | 0.660 |
Why?
|
| HIV Infections | 1 | 2023 | 352 | 0.650 |
Why?
|
| Isoantibodies | 1 | 2019 | 29 | 0.620 |
Why?
|
| Epitopes | 1 | 2019 | 59 | 0.620 |
Why?
|
| HLA Antigens | 1 | 2019 | 52 | 0.610 |
Why?
|
| Blood Component Removal | 1 | 2018 | 10 | 0.600 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 28 | 0.590 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 99 | 0.590 |
Why?
|
| Plasma Exchange | 2 | 2015 | 25 | 0.580 |
Why?
|
| Blood Platelets | 2 | 2017 | 251 | 0.580 |
Why?
|
| Graft Rejection | 1 | 2019 | 172 | 0.570 |
Why?
|
| Tissue Donors | 1 | 2019 | 121 | 0.570 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 118 | 0.570 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2017 | 38 | 0.570 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2017 | 5 | 0.560 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 189 | 0.530 |
Why?
|
| Decision Making | 1 | 2019 | 272 | 0.520 |
Why?
|
| Aspirin | 1 | 2017 | 112 | 0.520 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 121 | 0.520 |
Why?
|
| Factor VIII | 2 | 2024 | 23 | 0.520 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2016 | 14 | 0.510 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 174 | 0.510 |
Why?
|
| Multiple Myeloma | 5 | 2019 | 2997 | 0.490 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2015 | 4 | 0.480 |
Why?
|
| Heparin | 1 | 2015 | 91 | 0.480 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 81 | 0.470 |
Why?
|
| Erythrocyte Transfusion | 1 | 2015 | 52 | 0.470 |
Why?
|
| ADAM Proteins | 1 | 2014 | 20 | 0.460 |
Why?
|
| Bordetella pertussis | 1 | 2013 | 3 | 0.450 |
Why?
|
| Whooping Cough | 1 | 2013 | 12 | 0.440 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 94 | 0.430 |
Why?
|
| Cell Nucleus | 1 | 2013 | 182 | 0.420 |
Why?
|
| Partial Thromboplastin Time | 1 | 2012 | 12 | 0.420 |
Why?
|
| Prothrombin Time | 1 | 2012 | 18 | 0.410 |
Why?
|
| Lymphocytes | 1 | 2013 | 149 | 0.410 |
Why?
|
| Glycoproteins | 1 | 2012 | 116 | 0.390 |
Why?
|
| Paraproteinemias | 1 | 2012 | 72 | 0.390 |
Why?
|
| Humans | 17 | 2024 | 50509 | 0.330 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 90 | 0.280 |
Why?
|
| Adult | 6 | 2019 | 13583 | 0.260 |
Why?
|
| Blood Transfusion | 2 | 2017 | 129 | 0.250 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1033 | 0.240 |
Why?
|
| Retrospective Studies | 4 | 2018 | 6263 | 0.240 |
Why?
|
| Male | 8 | 2019 | 25910 | 0.240 |
Why?
|
| Hemophilia A | 1 | 2024 | 25 | 0.220 |
Why?
|
| Histoplasma | 1 | 2023 | 23 | 0.220 |
Why?
|
| Young Adult | 3 | 2019 | 4106 | 0.200 |
Why?
|
| Aged | 4 | 2019 | 9743 | 0.200 |
Why?
|
| Middle Aged | 5 | 2019 | 12614 | 0.200 |
Why?
|
| Female | 7 | 2019 | 27086 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2024 | 197 | 0.180 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 20 | 0.160 |
Why?
|
| Autoantibodies | 2 | 2024 | 115 | 0.160 |
Why?
|
| Hematocrit | 1 | 2018 | 43 | 0.150 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 75 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2018 | 58 | 0.150 |
Why?
|
| Medical Waste | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cell Aggregation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2019 | 169 | 0.140 |
Why?
|
| Platelet Count | 1 | 2017 | 65 | 0.140 |
Why?
|
| Lymphoma | 1 | 2018 | 67 | 0.140 |
Why?
|
| Lymphoma, Follicular | 1 | 2017 | 21 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2017 | 46 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2016 | 474 | 0.140 |
Why?
|
| Risk | 1 | 2017 | 324 | 0.130 |
Why?
|
| Fibrosis | 1 | 2017 | 181 | 0.130 |
Why?
|
| Antibodies | 1 | 2016 | 153 | 0.130 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 136 | 0.130 |
Why?
|
| Adolescent | 2 | 2019 | 6447 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 234 | 0.120 |
Why?
|
| Hemoglobin J | 1 | 2015 | 3 | 0.120 |
Why?
|
| Hemoglobin, Sickle | 1 | 2015 | 6 | 0.120 |
Why?
|
| Hemoglobin C | 1 | 2015 | 6 | 0.120 |
Why?
|
| Logistic Models | 1 | 2017 | 900 | 0.120 |
Why?
|
| Chylothorax | 1 | 2014 | 15 | 0.120 |
Why?
|
| Blood Donors | 1 | 2015 | 32 | 0.120 |
Why?
|
| Incidence | 1 | 2017 | 1032 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1199 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 181 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2012 | 32 | 0.100 |
Why?
|
| Prognosis | 1 | 2018 | 1978 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 225 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 578 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 325 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 641 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 307 | 0.100 |
Why?
|
| Arkansas | 1 | 2017 | 1984 | 0.090 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2010 | 2 | 0.090 |
Why?
|
| Leishmaniasis | 1 | 2010 | 2 | 0.090 |
Why?
|
| Tongue Diseases | 1 | 2010 | 7 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 978 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 3228 | 0.080 |
Why?
|
| Child | 2 | 2024 | 6910 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2013 | 3944 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2016 | 27 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 145 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2014 | 105 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 81 | 0.030 |
Why?
|
| Insect Vectors | 1 | 2010 | 5 | 0.020 |
Why?
|
| Psychodidae | 1 | 2010 | 2 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 2010 | 9 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2010 | 19 | 0.020 |
Why?
|
| Amphotericin B | 1 | 2010 | 102 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 588 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2747 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3630 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 13124 | 0.010 |
Why?
|